No Kings Day

Dr. Éliane Gluckman revolutionized #hematology by performing the 1st human cord blood transplant. Since then, there have been more than 40K transplants, with cord blood registries established worldwide. 🩸✨ Watch this video about her amazing career https://bit.ly/3DnxswP#hematology #ASH24 #Hemesky

Follow us all now #platelets #coagulation 🧪 #hemesky #cardiosky #Thrombosky

Orca-Q Leads to Low Rates of GVHD, Non-Relapse Mortality in High-Risk Hematologic Malignancies After Allo-HCT @ash-hematology.bsky.social #ASH24 #hematology #oncology www.onclive.com/view/orca-q-...

🌡️ Fever of Unknown Origin (FUO) = temp >38.3C multiple times x 3 weeks without obvious cause Infections: 20-40%. Connective tissue disorders: 20% Malignancy: 10-20% Undiagnosed: 20% Drugs (e.g., phenytoin): rare #medsky #IMsky #internalmedicine #IDsky #hemeonc #hemesky #oncsky #rheumsky

Out in @bloodjournal during #ASH24 - cool work by @freemanlciaraMD @DrFredLocke et al looking at #MMsm CAR-T in myeloma: MTV (by PET-CT), sBCMA, BMPC don't always correlate. Some MTV-high but sBCMA-low pts exist - may not respond durably to BCMA CAR-T. ashpublications.org/blood/articl...

Staggering statistics at #ASH24 #TreatingFairly Patients with cancer who go bankrupt are nearly 80% more likely to die regardless of disease status. Our system quite literally kills people.

Megan Melody presenting important data on bi specific antibodies after CAR T progression at ASH24

Wisdom doesn’t come from experience. It comes from reflecting on experience. Between ages 25 and 75, the correlation between age and wisdom is zero. Gaining insight and perspective is not about the number of years you've lived. It's about the number of lessons you've learned.

Scientists have made major strides in engineering CAR-T cell therapies to treat autoimmune disorders such as lupus, according to a new #ScienceTranslationalMedicine Review that discusses the latest breakthroughs and clinical trials in the field. scim.ag/4f0RmL1

The possible “catastrophic success” of CAR-T cells in cancer and autoimmune disease @science.org. A nice story on dramatic diseases, biomedical technology and sustainability.. bit.ly/4i9FXf1 #oncosky #medsky #oncsky 🧪

MRD-adapted 1L ven+obin CLL #ASH24: - MRD stopping criteria below - 100 pts, 16% TP53mut - 2-yr PFS/OS 92%/95% - 41 pts uMRD6 at C7, 3 pts req'd all 24 cycles Great to stop VO even earlier for pts w/ early uMRD. #lymsm

Such a thoughtful way to share thanks!